{"id":106671,"date":"2025-10-09T17:12:35","date_gmt":"2025-10-09T15:12:35","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/?p=106671"},"modified":"2025-10-13T15:10:51","modified_gmt":"2025-10-13T13:10:51","slug":"cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/","title":{"rendered":"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores"},"content":{"rendered":"<p><strong>La empresa biotecnol\u00f3gica <a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/ona-therapeutics\/\" target=\"_blank\" rel=\"noopener\">Ona Therapeutics<\/a>, ubicada en el Parque Cient\u00edfico de Barcelona, ha recibido una inversi\u00f3n de 10 millones de euros, liderada por la SICC Innvierte del CDTI Innovaci\u00f3n, para avanzar en el desarrollo de nuevas terapias contra el c\u00e1ncer avanzado mediante ADCs (anticuerpos conjugados con f\u00e1rmacos). La operaci\u00f3n tambi\u00e9n ha contado con la participaci\u00f3n de los coinversores Asabys Partners, Ysios Capital Partners, Alta Life Science, el Fondo de Capital Riesgo Europeo (FCRE) y Fund+. Los fondos se destinar\u00e1n a la creaci\u00f3n de ADC y terapias basadas en anticuerpos, con el objetivo de ofrecer nuevas opciones de tratamiento para pacientes con c\u00e1ncer avanzado, hasta ahora sin alternativas efectivas.<\/strong><\/p>\n<p data-start=\"1079\" data-end=\"1719\">Ona Therapeutics es pionera en el desarrollo de conjugados anticuerpo-f\u00e1rmaco de primera generaci\u00f3n que aprovechan las bases moleculares del c\u00e1ncer avanzado. La compa\u00f1\u00eda trabaja en colaboraci\u00f3n con acad\u00e9micos y m\u00e9dicos expertos para dise\u00f1ar terapias que respondan a la complejidad de la enfermedad y cubran necesidades cl\u00ednicas no satisfechas. Los pacientes con c\u00e1ncer avanzado suelen haber recibido m\u00faltiples l\u00edneas de tratamiento, y su evoluci\u00f3n presenta desaf\u00edos significativos debido a la limitada comprensi\u00f3n de c\u00f3mo cambia el c\u00e1ncer a lo largo de estas terapias, dificultando la identificaci\u00f3n de nuevas dianas terap\u00e9uticas.<\/p>\n<p data-start=\"1721\" data-end=\"2192\">Esta spin-off del Instituto de Investigaci\u00f3n Biom\u00e9dica (<a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/institut-de-recerca-biomedica-irb-barcelona\/\" target=\"_blank\" rel=\"noopener\">IRB Barcelona<\/a>) aplica un enfoque innovador incorporando muestras de pacientes refractarios, lo que permite analizar c\u00f3mo el tratamiento est\u00e1ndar transforma el c\u00e1ncer a nivel molecular. Gracias a este conocimiento, Ona Therapeutics puede identificar nuevas dianas terap\u00e9uticas m\u00e1s all\u00e1 de los ant\u00edgenos tumorales tradicionales y definir poblaciones de pacientes donde estas terapias ser\u00e1n m\u00e1s eficaces.<\/p>\n<p data-start=\"2194\" data-end=\"2405\">Con esta inversi\u00f3n, Ona Therapeutics refuerza su estrategia de desarrollo de ADC y terapias basadas en anticuerpos, consolid\u00e1ndose como una empresa de referencia en la innovaci\u00f3n contra el c\u00e1ncer avanzado.<\/p>\n<p data-start=\"2194\" data-end=\"2405\"><strong>\u00bb Enlace a la noticia: <\/strong><a href=\"https:\/\/www.cdti.es\/noticias\/sicc-innvierte-cdti-innovacion-coinversion-ona-therapeutics-terapias-cancer\" target=\"_blank\" rel=\"noopener\">web del CDTI [+]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La empresa biotecnol\u00f3gica Ona Therapeutics, ubicada en el Parque Cient\u00edfico de Barcelona, ha recibido una inversi\u00f3n de 10 millones de euros, liderada por la SICC Innvierte del CDTI Innovaci\u00f3n, para&#8230;<\/p>\n","protected":false},"author":14,"featured_media":106672,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[267],"class_list":["post-106671","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas","tag-ona-therapeutics-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"description\" content=\"La operaci\u00f3n ha contado con la participaci\u00f3n de Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE y Fund+.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La operaci\u00f3n ha contado con la participaci\u00f3n de Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE y Fund+.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-09T15:12:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:10:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores\",\"datePublished\":\"2025-10-09T15:12:35+00:00\",\"dateModified\":\"2025-10-13T13:10:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/\"},\"wordCount\":357,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"keywords\":[\"Ona Therapeutics\"],\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/\",\"name\":\"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"datePublished\":\"2025-10-09T15:12:35+00:00\",\"dateModified\":\"2025-10-13T13:10:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"description\":\"La operaci\u00f3n ha contado con la participaci\u00f3n de Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE y Fund+.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"width\":900,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores - Parc Cient\u00edfic de Barcelona","description":"La operaci\u00f3n ha contado con la participaci\u00f3n de Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE y Fund+.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/","og_locale":"es_ES","og_type":"article","og_title":"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores - Parc Cient\u00edfic de Barcelona","og_description":"La operaci\u00f3n ha contado con la participaci\u00f3n de Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE y Fund+.","og_url":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2025-10-09T15:12:35+00:00","article_modified_time":"2025-10-13T13:10:51+00:00","og_image":[{"width":900,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores","datePublished":"2025-10-09T15:12:35+00:00","dateModified":"2025-10-13T13:10:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/"},"wordCount":357,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","keywords":["Ona Therapeutics"],"articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/","url":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/","name":"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","datePublished":"2025-10-09T15:12:35+00:00","dateModified":"2025-10-13T13:10:51+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"description":"La operaci\u00f3n ha contado con la participaci\u00f3n de Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE y Fund+.","breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","width":900,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/cdti-innovacion-lidera-una-inversion-de-10-millones-de-euros-en-ona-therapeutics-junto-con-cinco-coinversores\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"CDTI Innovaci\u00f3n lidera una inversi\u00f3n de 10 millones de euros en Ona Therapeutics junto con cinco coinversores"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/106671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=106671"}],"version-history":[{"count":3,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/106671\/revisions"}],"predecessor-version":[{"id":106679,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/106671\/revisions\/106679"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/106672"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=106671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=106671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=106671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}